A Study About Safety and Efficacy of Pirfenidone to Treat Grade 2 or Grade3 Radiation-induced Lung Injury.

NCT03902509 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Radiation-induced Lung Injury

Interventions

DRUG: Pirfenidone
DRUG: basic treatment

Sponsor

Beijing Continent Pharmaceutical Co, Ltd.